Cargando…

Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials

BACKGROUND: Complementary medicines (CM) are frequently used by patients with cancer. Controversy exists over the effectiveness and risk that CM may add to conventional cancer therapy. The incidence of CM use among patients enrolled in phase III clinical trials is unknown. METHODS: Medication lists...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wells, J Connor, Sidhu, Aven, Ding, Keyue, Smoragiewicz, Martin, Heng, Daniel Y C, Shepherd, Frances A, Ellis, Peter M, Bradbury, Penelope A, Jonker, Derek J, Siu, Lillian L, Gelmon, Karen A, Karapetis, Christos, Shapiro, Jeremy, Nott, Louise, O’Callaghan, Christopher J, Parulekar, Wendy R, Seymour, Lesley, Monzon, Jose G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Symptom Management and Supportive Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914495/ https://www.ncbi.nlm.nih.gov/pubmed/35274718 http://dx.doi.org/10.1093/oncolo/oyac020

Ejemplares similares

The Value of In Vivo Reflectance Confocal Microscopy as an Assessment Tool in Chemotherapy-Induced Peripheral Neuropathy: A Pilot Study
por: Ramnarine, Sabrina R, et al.
Publicado: (2022)

Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial
por: van der Vorst, Maurice J.D.L., et al.
Publicado: (2019)

Longitudinal Changes in Skeletal Muscle Metabolism, Oxygen Uptake, and Myosteatosis During Cardiotoxic Treatment for Early-Stage Breast Cancer
por: Kirkham, Amy A, et al.
Publicado: (2022)

Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer
por: Nipp, Ryan D., et al.
Publicado: (2017)

Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer
por: van der Velden, Naomi Cornelia Anna, et al.
Publicado: (2023)

Use of Antidepressant Medications Moderates the Relationship Between Depressive Symptoms and Hospital Length of Stay in Patients with Advanced Cancer
por: Wong, Risa L., et al.
Publicado: (2018)

Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy‐Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial
por: van der Vorst, Maurice J.D.L., et al.
Publicado: (2020)

Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)
por: Navari, Rudolph M, et al.
Publicado: (2023)

Quality of Life Associated with Nausea and Vomiting from Anthracycline‐Based Chemotherapy: A Pooled Data Analysis from Three Prospective Trials
por: Yeo, Winnie, et al.
Publicado: (2021)

Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial
por: Henselmans, Inge, et al.
Publicado: (2019)

Heterogeneity in Quality of Life of Long‐Term Colon Cancer Survivors: A Latent Class Analysis of the Population‐Based PROFILES Registry
por: Clouth, Felix J., et al.
Publicado: (2021)

Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung Cancer
por: Nipp, Ryan D., et al.
Publicado: (2016)

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines
por: Lacouture, Mario E., et al.
Publicado: (2020)

Opioid Risk Mitigation Practices of Interprofessional Oncology Personnel: Results From a Cross-Sectional Survey
por: McNally, Gretchen A, et al.
Publicado: (2023)

The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities
por: Klesse, Laura J., et al.
Publicado: (2020)

Effects of Early Integrated Palliative Care on Caregivers of Patients with Lung and Gastrointestinal Cancer: A Randomized Clinical Trial
por: El‐Jawahri, Areej, et al.
Publicado: (2017)

Open-Label Placebo for the Treatment of Cancer-Related Fatigue in Patients with Advanced Cancer: A Randomized Controlled Trial
por: Yennurajalingam, Sriram, et al.
Publicado: (2022)

Eflapegrastim, a Long‐Acting Granulocyte‐Colony Stimulating Factor for the Management of Chemotherapy‐Induced Neutropenia: Results of a Phase III Trial
por: Schwartzberg, Lee S., et al.
Publicado: (2020)

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy
por: Schwartzberg, Lee, et al.
Publicado: (2019)

Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia
por: El‐Jawahri, Areej, et al.
Publicado: (2018)

The EORTC QLQ‐C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the “Real‐World”: Results from the Population‐Based PROFILES Registry
por: Husson, Olga, et al.
Publicado: (2019)

Smoking Is Related to Worse Cancer-related Symptom Burden
por: Oswald, Laura B, et al.
Publicado: (2022)

Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience
por: Albaba, Hamzeh, et al.
Publicado: (2019)

Use of Palliative Care Services in a Tertiary Cancer Center
por: Dalal, Shalini, et al.
Publicado: (2016)

Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors
por: Hofheinz, Ralf-Dieter, et al.
Publicado: (2016)

Development of Palliative Care in China: A Tale of Three Cities
por: Yin, Zhenyu, et al.
Publicado: (2017)

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2017)

Pattern and Predictors of Outpatient Palliative Care Referral Among Thoracic Medical Oncologists
por: Hui, David, et al.
Publicado: (2018)

Phase Angle and the Diagnosis of Impending Death in Patients with Advanced Cancer: Preliminary Findings
por: Hui, David, et al.
Publicado: (2018)

Permanent Chemotherapy‐Induced Alopecia in Patients with Breast Cancer: A 3‐Year Prospective Cohort Study
por: Kang, Danbee, et al.
Publicado: (2018)

A Prospective Observational Study on Effect of Short‐Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO‐01)
por: Nakamura, Michio, et al.
Publicado: (2017)

Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?
por: van Prehn, Joffrey, et al.
Publicado: (2017)

Implementation of the Edmonton Symptom Assessment System for Symptom Distress Screening at a Community Cancer Center: A Pilot Program
por: Hui, David, et al.
Publicado: (2017)

Referral Criteria for Outpatient Palliative Cancer Care: A Systematic Review
por: Hui, David, et al.
Publicado: (2016)

Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow‐Up Survey
por: Kakkar, Ajay K., et al.
Publicado: (2020)

Impact on Health‐Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial
por: Bouleuc, Carole, et al.
Publicado: (2020)

One‐Day Versus Three‐Day Dexamethasone in Combination with Palonosetron for the Prevention of Chemotherapy‐Induced Nausea and Vomiting: A Systematic Review and Individual Patient Data‐Based Meta‐Analysis
por: Okada, Yuki, et al.
Publicado: (2019)

A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities
por: Kim, Young Saing, et al.
Publicado: (2019)

Ambulation Recovery After Surgery for Metastases to the Femur
por: Kim, Yongsung, et al.
Publicado: (2019)

A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin‐Based Chemotherapy‐Induced Nausea and Vomiting in Japan
por: Iihara, Hirotoshi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pc87gpod6o7uuoji5l0o8sgvos